Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADP vs MRNA✓SelectedUSD · MRNAADP vs MRNA performance historyLatest closeAs of+0.65%11/13
Stock and ETF performance explorer

ADP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+25.3%
MRNA return
+755.5%
Excess return
-730.2%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.7%-3.4%+4.1%+0.7%
7D+2.2%-12.1%+14.3%+2.3%
30D+10.6%-1.3%+11.9%+10.5%
3M+12.9%+250.9%-238.0%+9.9%
6M+50.6%+343.0%-292.4%+47.7%
YTD+23.2%+657.4%-634.3%+18.7%
1Y+25.3%+794.9%-769.7%+18.4%
All+25.3%+755.5%-730.2%+18.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling